Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu et al. · Signal Transduction and Targeted Therapy · 2023 · Randomised trial
Full textCC BY